Skip to main content
. 2017 Mar 28;112(6):1105–1119. doi: 10.1016/j.bpj.2017.01.020

Figure 1.

Figure 1

Illustration of structures of CaM and sequences of the target peptides. (a) Solution structure of Ca2+-free CaM (apoCaM) (PDB: 1CFD) and crystal structure of Ca2+/CaM (holoCaM) (PDB: 1CLL). CaM is colored as follows, red → nCaM (residue 1–76), gray → central linker (residue 77–82), blue → cCaM (residue 83–148), and the Ca2+ ions are colored in green; Ca2+ binding sites are labeled from I to IV. (b) Structure of Ca2+/CaM-dependent kinase II (CaMKII) peptide from the holoCaM-CaMKII crystal structure (PDB: 1CDM) and the sequence of the peptide. (c) X-ray structure of holoCaM-CaMKII (PDB: 1CDM). CaM and the Ca2+ ions are colored as in (a) and the CaMKII peptide is colored in green. (d) Sequence of the neurogranin peptide (Ng13–49). The two minimum compositions of the Ng13–49 peptide are marked as “acidic region” and “IQ motif.” To see this figure in color, go online.